Pharmacokinetics of amifostine: Effects of dose and method of administration

Seminars in Oncology

Volumn 26, Issue 2 SUPPL. 7, 1999, Pages 34-36

  Shaw, L M ^a   Bonner, H S ^a   Schuchter, L ^a   Schiller, J ^a   Lieberman, R ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; CANCER PATIENT; DOSE RESPONSE; DRUG EFFECT; ENDOTHELIUM CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TUBULE EPITHELIUM; MALE; MALIGNANT NEOPLASTIC DISEASE; NORMAL HUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; URINARY EXCRETION;

ADMINISTRATION, ORAL; AMIFOSTINE; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CYTOPROTECTION; HUMANS; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; MALE; PILOT PROJECTS; PROTECTIVE AGENTS;

EID: 0033029608     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)